Tibet Cheezheng Tibetan Medicine Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
April 28, 2022 at 03:53 am EDT
Share
Tibet Cheezheng Tibetan Medicine Co., Ltd. reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was CNY 407.58 million compared to CNY 328.76 million a year ago. Revenue was CNY 407.58 million compared to CNY 328.76 million a year ago. Net income was CNY 87.09 million compared to CNY 103.17 million a year ago. Basic earnings per share from continuing operations was CNY 0.1648 compared to CNY 0.1939 a year ago. Diluted earnings per share from continuing operations was CNY 0.1645 compared to CNY 0.1939 a year ago.
Tibet Cheezheng Tibetan Medicine Co., Ltd is a China-based company, principally engaged in the research, development, manufacture and distribution of Tibetan medicines. The Company primarily offers medicines under emplastrum, ointment, granule, crude drugs and others. The Company's products include external pain relieving series, including Cheezheng Xiaotong emplastrum, Qingpeng ointment and Baimai ointment, as well as oral medicine series. The Company distributes its products within domestic market and to overseas markets.
TIBET CHEEZHENG TIBETAN MEDICINE CO., LTD. 
